If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLVN.L Regulatory News (BLVN)

  • There is currently no data for BLVN

Director/PDMR Shareholding

20 Oct 2011 16:47

RNS Number : 5742Q
BowLeven Plc
20 October 2011
 

20 October 2011

 

Bowleven plc ("Bowleven" or the "Company")

 

Directors' interests

 

The Company announces that on 19 October 2011, pursuant to a conditional placing of 77,500,000 new ordinary shares in the capital of the Company at a placing price of 103 pence each, the following dealings (direct or indirect) by directors of Bowleven took place (in accordance with a derogation granted to the Company in respect of AIM rule 21) pursuant to the conditional placing:-

 

Ronnie Hanna, Non-Executive Chairman of the Company, has agreed to subscribe for 20,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, Ronnie Hanna's total beneficial shareholding in the Company will be 330,125 shares which at that time will represent approximately 0.11% of the then enlarged issued share capital of the Company.

 

Kevin Hart, Chief Executive Officer of the Company, has agreed to subscribe for 200,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, Kevin Hart's total beneficial shareholding in the Company will be 2,190,000 shares which at that time will represent approximately 0.75% of the then enlarged issued share capital of the Company.

 

John Brown, Finance Director of the Company, has agreed to subscribe for 25,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, John Brown's total beneficial shareholding in the Company will be 122,675 shares which at that time will represent approximately 0.04% of the then enlarged issued share capital of the Company.

 

Ed Willett, Exploration Director of the Company has agreed to subscribe for 25,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, Ed Willett's total beneficial shareholding in the Company will be 217,235 shares which at that time will represent approximately 0.07% of the then enlarged issued share capital of the Company.

 

Peter Wilson, Director and General Counsel of the Company, has agreed to subscribe for 25,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, Peter Wilson's total beneficial shareholding in the Company will be 277,119 shares which at that time will represent approximately 0.09% of the then enlarged issued share capital of the Company.

 

Tim Sullivan, Non-Executive Director of the Company, has agreed to subscribe for 50,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, Tim Sullivan's total beneficial shareholding in the Company will be 146,745 shares which at that time will represent approximately 0.05% of the then enlarged issued share capital of the Company.

 

The allotment of the new ordinary shares pursuant to the conditional placing is subject to, amongst other things, the required shareholder approval to be sought at the Company's General Meeting being held on Monday 7 November 2011.

 

ENQUIRIES

For further information please contact:

 

Bowleven plc

Kevin Hart, Chief Executive

00 44 131 524 5678

Kerry Crawford, Head of Investor Relations

BofA Merrill Lynch

00 44 207 628 1000

Andrew Osborne

Tony White

Brunswick Group LLP

Patrick Handley

00 44 207 404 5959

Natalia Erikssen

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSPGGQCUUPGGAU
Date   Source Headline
19th Nov 20204:41 pmRNSSecond Price Monitoring Extn
19th Nov 20204:36 pmRNSPrice Monitoring Extension
16th Nov 20204:36 pmRNSAnnual Financial Report
9th Nov 20204:40 pmRNSSecond Price Monitoring Extn
9th Nov 20204:36 pmRNSPrice Monitoring Extension
9th Nov 20207:00 amRNSBlock Admission Six Monthly Return
5th Nov 20207:00 amRNSPreliminary Results
2nd Nov 20204:41 pmRNSSecond Price Monitoring Extn
2nd Nov 20204:36 pmRNSPrice Monitoring Extension
2nd Nov 20207:00 amRNSBoard Change
7th Oct 20207:00 amRNSNotice of Results and Corporate Update
22nd Sep 20202:35 pmRNSEmployee Benefit Trust Shares Transfer
31st Jul 20204:40 pmRNSSecond Price Monitoring Extn
31st Jul 20204:36 pmRNSPrice Monitoring Extension
15th Jun 20204:41 pmRNSSecond Price Monitoring Extn
15th Jun 20204:35 pmRNSPrice Monitoring Extension
11th May 20207:00 amRNSBlock Admission Six Monthly Return
6th May 202012:07 pmRNSSecond Price Monitoring Extn
6th May 202012:02 pmRNSPrice Monitoring Extension
3rd Apr 20204:41 pmRNSSecond Price Monitoring Extn
3rd Apr 20204:35 pmRNSPrice Monitoring Extension
27th Mar 20207:00 amRNSInterim Results
18th Mar 20204:41 pmRNSSecond Price Monitoring Extn
18th Mar 20204:36 pmRNSPrice Monitoring Extension
10th Mar 20206:00 pmRNSTR-1: Notification of major holdings
4th Mar 20207:00 amRNSLead FEED contract awarded for Etinde
5th Feb 20207:13 amRNSLOI signed for supply of gas from Etinde
11th Dec 201912:30 pmRNSResult of AGM
10th Dec 20194:41 pmRNSSecond Price Monitoring Extn
10th Dec 20194:35 pmRNSPrice Monitoring Extension
9th Dec 20197:00 amRNSNotice of Investor Call
29th Nov 20196:31 pmRNSPosting of Annual Report and Accounts 2019
29th Nov 20197:07 amRNSPreliminary Results Announcement
22nd Nov 20194:45 pmRNSDate of Preliminary Results announcement
18th Nov 20197:00 amRNSPosting of Notice of Annual General Meeting 2019
11th Nov 20197:00 amRNSBlock Admission Six Monthly Return
7th Jun 20199:29 amRNSChange of Adviser
9th May 20197:00 amRNSBlock Admission Six Monthly Return
1st May 20194:41 pmRNSSecond Price Monitoring Extn
1st May 20194:35 pmRNSPrice Monitoring Extension
29th Mar 20197:00 amRNSInterim Results
8th Feb 20197:00 amRNSConfirmation of Special Dividend Payment
7th Jan 20197:32 amRNSProposed Special Dividend
12th Dec 20182:19 pmRNSResult of Annual General Meeting
19th Nov 20182:20 pmRNSPosting of Annual Report and Accounts 2018
9th Nov 20187:00 amRNSBlock Admission Six Monthly Return
8th Nov 20187:00 amRNSPreliminary Results Announcement
2nd Nov 20181:43 pmRNSTR-1: Notification of major holdings
26th Oct 20187:00 amRNSNotice of Investor Call
18th Oct 20189:17 amRNSResult of IE-4 well

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.